
Amber Clemmons PharmD, BCOP, FHOPA, highlights key changes in evidence grading, shared decision-making, and dosing strategies in neutropenia management.

Amber Clemmons PharmD, BCOP, FHOPA, highlights key changes in evidence grading, shared decision-making, and dosing strategies in neutropenia management.

This episode examines the importance of overall survival as a key endpoint in endometrial cancer, comparing emerging data for pembrolizumab and dostarlimab and how these findings influence immunotherapy selection and clinical decision-making.

This Pharmacy Times Peer Exchange episode discusses the growing clinical and economic burden of endometrial cancer, highlighting rising incidence, disparities in outcomes, and the need for improved screening, clinical trial enrollment, and evolving treatment strategies.

The pharmacists expressed a hopeful look toward the future of RSV immunization, expressing optimism about increasing vaccine uptake, expanding protection across populations, and the potential for new developments on the horizon.

Gwen Nichols shares her dream of changing the landscape of pediatric cancer research and care.

Pharmacists play a central role in shared decision-making by guiding patients through lipid-lowering options, cost considerations, and ongoing monitoring aligned with updated dyslipidemia guidelines.

Experts describe how infectious disease pharmacists drive antimicrobial stewardship, tackle resistance, and shape global training as SIDP marks 35 years.

Walgreens’ hybrid pharmacist pilot is delivering early positive results while serving as a foundational element of a broader workforce modernization strategy.

Walgreens’ hybrid pharmacist model combines in-store and centralized responsibilities to improve workforce flexibility.

Multidisciplinary breast cancer care boosts CDK4/6 adherence with nurse and pharmacy check-ins, targeted toxicity scripts, and early intervention to prevent drop-offs.

How multidisciplinary breast cancer teams use nurses and specialty pharmacists to catch CDK4/6 inhibitor toxicities early and keep patients on therapy.

Cristian Tomasetti, PhD, explains how obesity enlarges organs, raising cancer risk, and how GLP-1 weight loss therapy may reverse this, guiding oncology pharmacists.

LIV Process is a patented, water-based solution that allows hospitals and long-term care facilities to see live C difficile spores on surfaces in 2 minutes.

Insights on the growth of sports pharmacy and the increasing demand for pharmacist expertise in athlete care.


Pharmacists can improve statin adherence and refine triglyceride management by leveraging patient-centered counseling, adherence strategies, and updated guideline recommendations prioritizing statins and targeted adjunctive therapies.

There is a growing need to integrate pharmacists into sports medicine teams, where their expertise in medication safety, chronic disease management, and supplements can significantly enhance athlete care and performance.

This interview highlights the importance of integrating holistic health, lifestyle coaching, and medication management to create more effective, patient-centered care.

Pharmacists play a critical role in bridging athlete performance and safety, emphasizing foundational health habits, addressing supplement misconceptions, and supporting mental health through frequent, trusted patient interactions.

Travis Tygart, JD, discusses the growing risks of supplements and the critical need for education and vigilance to protect athletes and uphold clean sport.

Nilhan Uzman, MS, BPharm, discusses how pharmacists elevate athlete care by guiding safe use of medicines and supplements, debunking “natural” myths, and strengthening clean sport teams.

ASCO guidelines reshape multiple myeloma care with quadruplet induction, earlier CAR T-cell therapy and bispecifics, and selective smoldering treatment.

Kyle Fischer, PharmD, explains navigating payer hurdles, supporting adherence, and improving coordination in ILD and PAH care.

Amy Seung outlines her priorities for leading HOPA through evolving therapies, workforce challenges, and expanding pharmacy roles.

The panel examined the evolving reimbursement landscape for RSV vaccines, with a focus on the positive impact of the Inflation Reduction Act for Medicare Part D beneficiaries.

The panel discussed the expected side effects associated with RSV immunization, including common local reactions like pain and swelling at the injection site, as well as systemic effects such as fatigue, fever, and muscle aches.

This week's episode highlights new data on the newly approved oral GLP-1, orforglipron, the growing role of sports pharmacists, and FDA approval of a higher-dose regimen for spinal muscular atrophy.

Pharmacist Kyle Fischer, PharmD, APh, explains how antifibrotic therapy, drug interactions, and pharmacist–physician collaboration guide ILD care.


Learn how CDK4/6 inhibitor schedules vary and how pharmacists boost adherence, manage nausea, labs, QTc, and drug interactions.